These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11788696)

  • 1. Arterial embolization of unresectable hepatocellular carcinoma with use of cyanoacrylate and lipiodol.
    Loewe C; Cejna M; Schoder M; Thurnher MM; Lammer J; Thurnher SA
    J Vasc Interv Radiol; 2002 Jan; 13(1):61-9. PubMed ID: 11788696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arterial hepatic embolization of unresectable hepatocellular carcinoma using a cyanoacrylate/lipiodol mixture.
    Berghammer P; Pfeffel F; Winkelbauer F; Wiltschke C; Schenk T; Lammer J; Müller C; Zielinski C
    Cardiovasc Intervent Radiol; 1998; 21(3):214-8. PubMed ID: 9626437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arterial embolization of unresectable hepatocellular carcinoma with use of microspheres, lipiodol, and cyanoacrylate.
    Rand T; Loewe C; Schoder M; Schmook MT; Peck-Radosavljevic M; Kettenbach J; Wolf F; Schneider B; Lammer J
    Cardiovasc Intervent Radiol; 2005; 28(3):313-8. PubMed ID: 15886943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.
    Marelli L; Shusang V; Buscombe JR; Cholongitas E; Stigliano R; Davies N; Tibballs J; Patch D; Meyer T; Burroughs AK
    J Nucl Med; 2009 Jun; 50(6):871-7. PubMed ID: 19443599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Portal vein embolization with N-butyl cyanoacrylate before partial hepatectomy in patients with hepatocellular carcinoma and underlying cirrhosis or advanced fibrosis.
    Denys A; Lacombe C; Schneider F; Madoff DC; Doenz F; Qanadli SD; Halkic N; Sauvanet A; Vilgrain V; Schnyder P
    J Vasc Interv Radiol; 2005 Dec; 16(12):1667-74. PubMed ID: 16371534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Styrene maleic acid neocarzinostatin-transcatheter embolization for hepatocellular carcinoma--third report].
    Hasegawa I; Hirashima N
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):253-9. PubMed ID: 11865632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5 cm.
    Su TS; Lu HZ; Cheng T; Zhou Y; Huang Y; Gao YC; Tang MY; Jiang HY; Lian ZP; Hou EC; Liang P
    BMC Cancer; 2016 Nov; 16(1):834. PubMed ID: 27809890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome and prognostic factors of spontaneous ruptured hepatocellular carcinoma treated with transarterial embolization.
    Shin BS; Park MH; Jeon GS
    Acta Radiol; 2011 Apr; 52(3):331-5. PubMed ID: 21498371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis.
    Takayasu K; Arii S; Ikai I; Kudo M; Matsuyama Y; Kojiro M; Makuuchi M;
    AJR Am J Roentgenol; 2010 Mar; 194(3):830-7. PubMed ID: 20173167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of Lipiodol in transcatheter arterial embolization of hepatocellular carcinoma.
    Nakao N; Uchida H; Kamino K; Nishimura Y; Ohishi H; Takayasu Y; Nakamura H; Kuroda C; Fujita M; Yoshioka H
    Cancer Chemother Pharmacol; 1992; 31 Suppl():S72-6. PubMed ID: 1333913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of transcatheter embolization/chemoembolization (TAE/TACE) for the treatment of single hepatocellular carcinoma.
    Miraglia R; Pietrosi G; Maruzzelli L; Petridis I; Caruso S; Marrone G; Mamone G; Vizzini G; Luca A; Gridelli B
    World J Gastroenterol; 2007 Jun; 13(21):2952-5. PubMed ID: 17589945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arterial embolization of unresectable hepatocellular carcinoma with use of microspheres, lipiodol, and cyanoacrylate.
    Koizumi J
    Cardiovasc Intervent Radiol; 2006; 29(5):928; author reply 929. PubMed ID: 16502170
    [No Abstract]   [Full Text] [Related]  

  • 13. [Usefulness of transcatheter arterial embolization (TAE) for large hepatocellular carcinoma using a lecithin-added Lipiodol emulsion].
    Kobayashi S; Otsubo T; Koizumi S; Yoshitoshi K; Katagiri S; Furukawa T; Yamamoto M; Takasaki K
    Nihon Shokakibyo Gakkai Zasshi; 2007 Nov; 104(11):1601-6. PubMed ID: 17984608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.
    Takayasu K; Arii S; Ikai I; Omata M; Okita K; Ichida T; Matsuyama Y; Nakanuma Y; Kojiro M; Makuuchi M; Yamaoka Y;
    Gastroenterology; 2006 Aug; 131(2):461-9. PubMed ID: 16890600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcatheter arterial embolization in hepatocellular carcinoma: a long-term follow-up.
    Nakao N; Kamino K; Miura K; Takayasu Y; Ohnishi M; Miura T
    Radiat Med; 1992; 10(1):13-8. PubMed ID: 1316626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Embolization efficacy and treatment effectiveness of transarterial therapy for unresectable hepatocellular carcinoma: a case-controlled comparison of transarterial ethanol ablation with lipiodol-ethanol mixture versus transcatheter arterial chemoembolization.
    Yu SC; Hui JW; Hui EP; Mo F; Lee PS; Wong J; Lee KF; Lai PB; Yeo W
    J Vasc Interv Radiol; 2009 Mar; 20(3):352-9. PubMed ID: 19167240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcatheter arterial embolization for hepatocellular carcinoma with portal vein thrombosis.
    Yen FS; Wu JC; Kuo BI; Chiang JH; Chen TZ; Lee SD
    J Gastroenterol Hepatol; 1995; 10(3):237-40. PubMed ID: 7548796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sarcopenia as a predictor of survival in patients undergoing bland transarterial embolization for unresectable hepatocellular carcinoma.
    Lanza E; Masetti C; Messana G; Muglia R; Pugliese N; Ceriani R; Lleo de Nalda A; Rimassa L; Torzilli G; Poretti D; D'Antuono F; Politi LS; Pedicini V; Aghemo A;
    PLoS One; 2020; 15(6):e0232371. PubMed ID: 32555707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transarterial bland versus chemoembolization for hepatocellular carcinoma: rethinking a gold standard.
    Massarweh NN; Davila JA; El-Serag HB; Duan Z; Temple S; May S; Sada YH; Anaya DA
    J Surg Res; 2016 Feb; 200(2):552-9. PubMed ID: 26507276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival outcome of lobar or segmental transcatheter arterial embolization with ethanol-lipiodol mixture in treating hepatocellular carcinoma.
    Cheung YC; Ko SF; Ng SH; Chan SC; Cheng YF
    World J Gastroenterol; 2005 May; 11(18):2792-5. PubMed ID: 15884125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.